Genetic analysis of the S100B gene in Chinese patients with Parkinson disease

Neuroscience Letters

Volumn 555, Issue , 2013, Pages 134-136

  Guo, Yi ^a   Yang, Huarong ^a,b   Deng, Xiong ^a   Song, Zhi ^a   Yang, Zhijian ^a   Xiong, Wei ^a   Yuan, Lamei ^a   Xu, Hongbo ^a   Deng, Sheng ^c   Deng, Hao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Mutation; Parkinson disease; S100 calcium binding beta; The coding region

Indexed keywords

AMINO ACID; LEUCINE; PROTEIN S100B;

3' UNTRANSLATED REGION; AGED; ARTICLE; ASTROCYTE; CHINESE; EXON; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POPULATION; PRIORITY JOURNAL;

MUTATION; PARKINSON DISEASE; S100 CALCIUM-BINDING BETA; THE CODING REGION;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 84885798269     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.09.037     Document Type: Article

References (26)

1. Noyce A.J., Bestwick J.P., Silveira-Moriyama L., Hawkes C.H., Giovannoni G., Lees A.J., Schrag A. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann. Neurol. 2012, 72:893-901.
2. Xiu X., Song Z., Gao K., Deng X., Qi Y., Zhu A., Gong L., Deng H. Genetic analysis of the FBXO48 gene in Chinese Han patients with Parkinson's disease. Neurosci. Lett. 2013, 541:224-226.
3. Yuan L., Song Z., Xu H., Gu S., Zhu A., Gong L., Zhao Y., Deng H. EIF4G1 Ala502Val and Arg1205His variants in Chinese patients with Parkinson disease. Neurosci. Lett. 2013, 543:69-71.
4. Deng H., Liang H., Jankovic J. F-box only protein 7 gene in parkinsonian-pyramidal disease. JAMA Neurol. 2013, 70:20-24.
5. Fujioka S., Wszolek Z.K. Update on genetics of parkinsonism. Neurodegener. Dis. 2012, 10:257-260.
6. Gruden M.A., Sewell R.D., Yanamandra K., Davidova T.V., Kucheryanu V.G., Bocharov E.V., Bocharova O.R., Polyschuk V.V., Sherstnev V.V., Morozova-Roche L.A. Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression. J. Neuroimmunol. 2011, 233:221-227.
7. Sathe K., Maetzler W., Lang J.D., Mounsey R.B., Fleckenstein C., Martin H.L., Schulte C., Mustafa S., Synofzik M., Vukovic Z., Itohara S., Berg D., Teismann P. S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway. Brain 2012, 135:3336-3347.
8. Schaf D.V., Tort A.B., Fricke D., Schestatsky P., Portela L.V., Souza D.O., Rieder C.R. S100B and NSE serum levels in patients with Parkinson's disease. Parkinsonism Relat. Disord. 2005, 11:39-43.
9. Wilhelm K.R., Yanamandra K., Gruden M.A., Zamotin V., Malisauskas M., Casaite V., Darinskas A., Forsgren L., Morozova-Roche L.A. Immune reactivity towards insulin, its amyloid and protein S100B in blood sera of Parkinson's disease patients. Eur. J. Neurol. 2007, 14:327-334.
10. Jankovic J. Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 2008, 79:368-376.
11. Deng H., Xu H., Deng X., Song Z., Zheng W., Gao K., Fan X., Tang J. VPS35 mutation in Chinese Han patients with late-onset Parkinson's disease. Eur. J. Neurol. 2012, 19:e96-e97.
12. Zheng W., Deng X., Liang H., Song Z., Gao K., Yang Y., Deng H. Genetic analysis of the FUS gene in Chinese Han patients with essential tremor. Neurobiol. Aging 2013, 34:2078.e3-2078.e4.
13. Guo Y., Deng X., Zheng W., Xu H., Song Z., Liang H., Lei J., Jiang X., Luo Z., Deng H. HLA rs3129882 variant in Chinese Han patients with late-onset sporadic Parkinson disease. Neurosci. Lett. 2011, 501:185-187.
14. Chartier-Harlin M.C., Dachsel J.C., Vilariño-Güell C., Lincoln S.J., Leprêtre F., Hulihan M.M., Kachergus J., Milnerwood A.J., Tapia L., Song M.S., Le Rhun E., Mutez E., Larvor L., Duflot A., Vanbesien-Mailliot C., Kreisler A., Ross O.A., Nishioka K., Soto-Ortolaza A.I., Cobb S.A., Melrose H.L., Behrouz B., Keeling B.H., Bacon J.A., Hentati E., Williams L., Yanagiya A., Sonenberg N., Lockhart P.J., Zubair A.C., Uitti R.J., Aasly J.O., Krygowska-Wajs A., Opala G., Wszolek Z.K., Frigerio R., Maraganore D.M., Gosal D., Lynch T., Hutchinson M., Bentivoglio A.R., Valente E.M., Nichols W.C., Pankratz N., Foroud T., Gibson R.A., Hentati F., Dickson D.W., Destée A., Farrer M.J. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am. J. Hum. Genet. 2011, 89:398-406.
15. Wainwright M.S., Craft J.M., Griffin W.S., Marks A., Pineda J., Padgett K.R., Van Eldik L.J. Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia. Ann. Neurol. 2004, 56:61-67.
16. Sorci G., Bianchi R., Riuzzi F., Tubaro C., Arcuri C., Giambanco I., Donato R. S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond. Cardiovasc. Psychiatry Neurol. 2010, 2010. pii:656481.
17. Rothermundt M., Peters M., Prehn J.H., Arolt V. S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 2003, 60:614-632.
18. Liu J., Shi Y., Tang J., Guo T., Li X., Yang Y., Chen Q., Zhao X., He G., Feng G., Gu N., Zhu S., Liu H., He L. SNPs and haplotypes in the S100B gene reveal association with schizophrenia. Biochem. Biophys. Res. Commun. 2005, 328:335-341.
19. Roche S., Cassidy F., Zhao C., Badger J., Claffey E., Mooney L., Delaney C., Dobrin S., McKeon P. Candidate gene analysis of 21q22: support for S100B as a susceptibility gene for bipolar affective disorder with psychosis. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2007, 144B:1094-1096.
20. Lee H.J., Suk J.E., Patrick C., Bae E.J., Cho J.H., Rho S., Hwang D., Masliah E., Lee S.J. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J. Biol. Chem. 2010, 285:9262-9272.
21. Hu J., Ferreira A., Van Eldik L.J. S100beta induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 1997, 69:2294-2301.
22. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.K., Ischiropoulos H., Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 2002, 22:1763-1771.
23. Halliday G.M., Stevens C.H. Glia: initiators and progressors of pathology in Parkinson's disease. Mov. Disord. 2011, 26:6-17.
24. Muramatsu Y., Kurosaki R., Watanabe H., Michimata M., Matsubara M., Imai Y., Araki T. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Glia 2003, 42:307-313.
25. Liu J., Wang H., Zhang L., Xu Y., Deng W., Zhu H., Qin C. S100B transgenic mice develop features of Parkinson's disease. Arch. Med. Res. 2011, 42:1-7.
26. Marxreiter F., Ettle B., May V.E., Esmer H., Patrick C., Kragh C.L., Klucken J., Winner B., Riess O., Winkler J., Masliah E., Nuber S. Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice. Neurobiol. Dis. 2013, 59C:38-51.